Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine

aGastroenterology Division, Internal Medicine Department bDepartment of General Surgery, Bezmialem Vakif University Hospital, Istanbul, Turkey Received 3 December 2019 Accepted 4 January 2020 Correspondence to Metin Basaranoglu, MD, Division of Gastroenterology, Department of Internal Medicine, Bezmialem Vakif University Medical School, Asagi Gureba Fatih, 34000 Istanbul, Turkey, Tel: +90 212 554 0000; fax: +90 212 554 0000; e-mail: [email...